|
1
|
Emons G and Mallmann P; acting for the
Uterus Commission of AGO: Recommendations for the Diagnosis and
Treatment of Endometrial Cancer, Update 2013. Geburtshilfe
Frauenheilkd. 74:244–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Husmann G, Kaatsch P, Katalinic A, Bertz
J, Haberland J, Kraywinkel K and Wolf U: Cancer in Germany
2005/2006. Incidence and Trends. 7th edition. Robert Koch Institute
and Association of Population-based Cancer Registries in Germany;
Berlin: 2010
|
|
3
|
Emons G and Heyl W: Hormonal treatment of
endometrial cancer. J Cancer Res Clin Oncol. 126:619–623. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hecht JL and Mutter GL: Molecular and
pathologic aspects of endometrial carcinogenesis. J Clin Oncol.
24:4783–4791. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moodley M and Roberts C: Clinical pathway
for the evaluation of postmenopausal bleeding with an emphasis on
endometrial cancer detection. J Obstet Gynaecol. 24:736–741. 2004.
View Article : Google Scholar
|
|
6
|
Marsden DE and Hacker NF: Optimal
management of endometrial hyperplasia. Best Pract Res Clin Obstet
Gynaecol. 15:393–405. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tumorzentrum M: Malignome des Corpus
Uteri. PD Dr. PMKaPRK Christian Dann ecker : W. Zuckerschwendt
Verlag; Munich, Vienna, New York: 2007, In German.
|
|
8
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote I: Treatment modalities in endometrial
cancer. Curr Opin Oncol. 19:479–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beckmann K, Iosifidis P, Shorne L,
Gilchrist S and Roder D: Effects of variations in hysterectomy
status on population coverage by cervical screening. Aust N Z J
Public Health. 27:507–512. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Franken B, de Groot MR, Mastboom WJ,
Vermes I, van der Palen J, Tibbe AG and Terstappen LW: Circulating
tumor cells, disease recurrence and survival in newly diagnosed
breast cancer. Breast Cancer Res. 14:R1332012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bragado P, Sosa MS, Keely P, Condeelis J
and Aguirre-Ghiso JA: Microenvironments dictating tumor cell
dormancy. Recent Results Cancer Res. 195:25–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Diel IJ, Solomayer EF, Costa SD, Gollan C,
Goerner R, Wallwiener D, Kaufmann M and Bastert G: Reduction in new
metastases in breast cancer with adjuvant clodronate treatment. N
Engl J Med. 339:357–363. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pantel K and Woelfle U: Micrometastasis in
breast cancer and other solid tumors. J Biol Regul Homeost Agents.
18:120–125. 2004.PubMed/NCBI
|
|
14
|
Riethdorf S and Pantel K: Disseminated
tumor cells in bone marrow and circulating tumor cells in blood of
breast cancer patients: Current state of detection and
characterization. Pathobiology. 75:140–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ring A, Smith IE and Dowsett M:
Circulating tumor cells in breast cancer. Lancet Oncol. 5:79–88.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smerage JB and Hayes DF: The measurement
and therapeutic implications of circulating tumor cells in breast
cancer. Br J Cancer. 94:8–12. 2006. View Article : Google Scholar
|
|
17
|
Graves H and Czerniecki BJ: Circulating
tumor cells in breast cancer patients: An evolving role in patient
prognosis and disease progression. Patholog Res Int.
2011:6210902011.PubMed/NCBI
|
|
18
|
Hermanek P, Hutter RV, Sobin LH and
Wittekind C: International union against cancer. Classification of
isolated tumor cells and micrometastasis. Cancer. 86:2668–2673.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singletary SE, Patel-Parekh L and Bland
KI: Treatment trends in early-stage invasive lobular carcinoma: A
report from the national cancer data base. Ann Surg. 242:281–289.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghossein RA, Carusone L and Bhattacharya
S: Molecular detection of micrometastases and circulating tumor
cells in melanoma prostatic and breast carcinomas. In Vivo.
14:237–250. 2000.PubMed/NCBI
|
|
21
|
Andergassen U, Hofmann S, Kölbl AC,
Schindlbeck C, Neugebauer J, Hutter S, Engelstädter V, Ilmer M,
Friese K and Jeschke U: Detection of tumor cell-specific mRNA in
the peripheral blood of patients with breast cancer-evaluation of
several markers with real-time reverse transcription-PCR. Int J Mol
Sci. 14:1093–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andergassen U, Kölbl AC, Hutter S, Friese
K and Jeschke U: Detection of circulating tumor cells from blood of
breast cancer patients via RT-qPCR. Cancers (Basel). 5:1212–1220.
2013. View Article : Google Scholar
|
|
23
|
Zebisch M, Kölbl AC, Schindlbeck C,
Neugebauer J, Heublein S, Ilmer M, Rack B, Friese K, Jeschke U and
Andergassen U: Quantification of breast cancer cells in peripheral
blood samples by real-time rt-PCR. Anticancer Res. 32:5387–5391.
2012.PubMed/NCBI
|
|
24
|
Bogani G, Liu MC, Dowdy SC, Cliby WA, Kerr
SE, Kalli KR, Kipp BR, Halling KC, Campion MB and Mariani A:
Detection of circulating tumor cells in high-risk endometrial
cancer. Anticancer Res. 35:683–687. 2015.PubMed/NCBI
|
|
25
|
Alonso-Alconada L, Muinelo-Romay L,
Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D,
Coenegrachts L, Cano A, et al: Molecular profiling of circulating
tumor cells links plasticity to the metastatic process in
endometrial cancer. Mol Cancer. 13:2232014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cassia R, Moreno-Bueno G,
Rodriguez-Perales S, Hardisson D, Cigudosa JC and Palacios J:
Cyclin E gene (CCNE) amplification and hCDC4 mutations in
endometrial carcinoma. J Pathol. 201:589–595. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Obermayr E, Sanchez-Cabo F, Tea MK, Singer
CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R,
Heinze G, et al: Assessment of a six gene panel for the molecular
detection of circulating tumor cells in the blood of female cancer
patients. BMC Cancer. 10:6662010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Phillips TM and Lindsey JS: Carcinoma
cell-specific Mig-7: A new potential marker for circulating and
migrating cancer cells. Oncol Rep. 13:37–44. 2005.
|
|
29
|
Kurec AS, Baltrucki L, Mason DY and Davey
FR: Use of the APAAP method in the classification and diagnosis of
hematologic disorders. Clin Lab Med. 8:223–236. 1988.PubMed/NCBI
|
|
30
|
Noack F, Schmitt M, Bauer J, Helmecke D,
Krüger W, Thorban S, Sandherr M, Kuhn W, Graeff H and Harbeck N: A
new approach to phenotyping disseminated tumor cells:
Methodological advances and clinical implications. Int J Biol
Markers. 15:100–104. 2000.PubMed/NCBI
|
|
31
|
Pan XY, Li X, Che YC, Li HY, Li X, Zhang Y
and Yang X: Overexpression of claudin-4 may be involved in
endometrial tumorigenesis. Oncol Lett. 5:1422–1426. 2013.PubMed/NCBI
|
|
32
|
Classen-Linke I, Moss S, Gröting K, Beier
HM, Alfer J and Krusche CA: Mammaglobin 1: Not only a
breast-specific and tumor-specific marker, but also a
hormone-responsive endometrial protein. Histopathology. 61:955–965.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Plante BJ, Lessey BA, Taylor RN, Wang W,
Bagchi MK, Yuan L, Scotchie J, Fritz MA and Young SL: G
protein-coupled estrogen receptor (GPER) expression in normal and
abnormal endo-metrium. Reprod Sci. 19:684–693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sugimoto T, Koizumi T, Sudo T, Yamaguchi
S, Kojima A, Kumagai S and Nishimura R: Correlative expression of
cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor
type-2 (Her-2) in endometrial cancer. Kobe J Med Sci. 53:177–187.
2007.
|
|
35
|
Pugh CW and Ratcliffe PJ: Regulation of
angiogenesis by hypoxia: Role of the HIF system. Nat Med.
9:677–684. 2003. View Article : Google Scholar
|
|
36
|
Arcangeli A, Noci I, Fortunato A and
Scarselli GF: The LH/hCG axis in endometrial cancer: A new target
in the treatment of recurrent or metastatic disease. Obstet Gynecol
Int. 2010:pii: 486164. 2010.PubMed/NCBI
|
|
37
|
Davies S, Bax CM, Chatzaki E, Chard T and
Iles RK: Regulation of endometrial cancer cell growth by
luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br
J Cancer. 83:1730–1734. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pike MC, Peters RK, Cozen W, Probst-Hensch
NM, Felix JC, Wan PC and Mack TM: Estrogen-progestin replacement
therapy and endometrial cancer. J Natl Cancer Inst. 89:1110–1116.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noci I, Pillozzi S, Lastraioli E, Dabizzi
S, Giachi M, Borrani E, Wimalasena J, Taddei GL, Scarselli G and
Arcangeli A: hLH/hCG-receptor expression correlates with in vitro
invasiveness in human primary endometrial cancer. Gynecol Oncol.
111:496–501. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fernández-Shaw S, Shorter SC, Naish CE,
Barlow DH and Starkey PM: Isolation and purification of human
endometrial stromal and glandular cells using immunomagnetic
microspheres. Hum Reprod. 7:156–161. 1992.PubMed/NCBI
|
|
41
|
Zhang L, Rees MC and Bicknell R: The
isolation and long-term culture of normal human endometrial
epithelium and stroma. Expression of mRNAs for angiogenic
polypeptides basally and on oestrogen and progesterone challenges.
J Cell Sci. 108:323–331. 1995.PubMed/NCBI
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
43
|
Dawe CJ, Banfield WG, Morgan WD, Slatick
MS and Curth HO: Growth in continuous culture, and in hamsters, of
cells from a neoplasm associated with acanthossi nigricans. J Natl
Cancer Inst. 33:441–456. 1964.PubMed/NCBI
|
|
44
|
Kuramoto H: Studies of the growth and
cytogenetic properties of human endometrial adenocarcinoma in
culture and its development into an established line. Acta Obstet
Gynaecol Jpn. 19:47–58. 1972.PubMed/NCBI
|
|
45
|
Lessey BA, Ilesanmi AO, Castelbaum AJ,
Yuan L, Somkuti SG, Chwalisz K and Satyaswaroop PG:
Characterization of the functional progesterone receptor in an
endometrial adenocarcinoma cell line (Ishikawa):
Progesterone-induced expression of the alpha1 integrin. J Steroid
Biochem Mol Biol. 59:31–39. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hendricks DT, Taylor R, Reed M and Birrer
MJ: FHIT gene expression in human ovarian, endometrial, and
cervical cancer cell lines. Cancer Res. 57:2112–2115.
1997.PubMed/NCBI
|
|
47
|
Way DL, Grosso DS, Davis JR, Surwit EA and
Christian CD: In Vitro. 19:147–158. 1983. View Article : Google Scholar : PubMed/NCBI
|
